{"ticker": {"uuid": "1220d327-fd14-4a2c-ba79-b24e39549f81", "symbol": "HEMO", "name": "Hemogenyx Pharmaceuticals Plc", "exchange": "LSE", "country": "GB", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPVzBaSG8tTXJoOGhTRFo0aVNBa0ZGSGtnQXJEUlRPdUVISWt6OEVnRjk2OW15TkNMTThpbUhDU0xpTzBVWkU4b05UNnhxNWIzMmlkOFhTbnF0UDNsRWEzTEVKbWpKUk9GVWRfWldHMXpvZm5PR194M1ZhMGFrWWRHMGV2WHNaTmFZQVJHWnNlbTUzSTU2dnA0dTdVandlMlVvR2Nmc3FZNDc3ZVJmbi13azZwX0RSUFJNX3c?oc=5", "source_name": "Barchart.com", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemogenyx Issues Director Options During FTSE AIM Developments", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPQ2NZX3BvN0x4aTVyWFZhcm43MnFfUDE3Rnc0bzZyU2ZRVTBxVXdXWXdqRHpodFdwb3hKRWItcUVPVmZZVmxON04td2VBb3NHMlZaZzJkMEJHTXFySXVzT2lTSzRuc3BQSEtlUFBTQlhGa2d2VFRXa1p6T04wZnp2NW1pZUtNX2dVV3U0LXV1bnFHaTdjMFZDbHc3V1BRMlVnRVl5REtHSEQzQW8?oc=5", "source_name": "Kalkine Media", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemogenyx opens child arm in cell therapy trial after safety signoff", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOU012UDVBZll3NmNKZlMyS0FVbUJqMDAzWGlvRUY4ZHEwcmpYQmZtMGYtV2c1alUzUER1WktvbmJGVXVucnl4VW55SmpEYjJXOTZHdy01WHMyWmFhVEU5ZXVkRWJhNFR3SGsybEtCcUdUdFVVem1VNmt2ZVVuc3lYRzZwUS1DS3dYZHhtZzA5WmR5VzRIejQ5c3dLZVM3VEJVREdB?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemogenyx Pharmaceuticals PLC Announces Final Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPemRFMEpSbzZUdjh1dnVoa3ZLZVU2Y1FuNzJUNG11SVpvTWpUQVJjOXA4YXlla0dpcEVLS2l2QzZYdjJIcnBNMWg5WWd1dGZfZEJqWEhGSktlTDkxWWZBMXV1RC1RWUFOLWxHemdHYW0wZVRLRlQxVTE3OGhRMDI5VUhYTWE4OUhJSm42Y3lUTzJlVllVRGZDcVN0X1dHZnlZb0hVcnp2VFNLZFAzLUNkdzdiZWU?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "\u00a33M backs Hemogenyx leukemia trial and Estonia manufacturing", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOM3FIVVVRbHAzc050bWY2TS1zazBaR1R0bXdVcVJsaGJNRTIwUnZIa1lIY3BqdXRQcWRwc2NRcHZxVzlTR3VnWEx1Y3NCSlVkNDVzQ2daZ0R3aTNXYW9xRVF0M3l6ZlJOZE9SazJObl8zTURuN3ppVUpIVEQtX3pSRkhBdzdnUXBtcVVKMkExczFYWWhjZ0Nob2RxdWhRNzVPeHkwSl9ManRYbVMwOVE?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buyers At Hemogenyx Pharmaceuticals Sitting On UK\u00a32.3m Profit", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemogenyx Pharmaceuticals (LSE:HEMO) Market Movement Within FTSE Structure", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOV2l6Q2xVN2ZhR2JrODdFSEtlQUhrOUx4NTQ3Q29hb1hxWFh4bkRYMEUzRldiNjFWdGxxRW9oajhNRkdmS2JubjlPVWxNbUtkcVFYdjM0X2FVTTk1TmxwMUY1cGJtdzFvc2ptVGxRdWFZTzlLSFJNZFBMd1JDS2V0R1VkOXNhWkxTbmtmUkN5S0ZRM2hOR2lCNC1CVVRYTy1iXzF6SWFlLVVsYVp5LUVTbVFSVGFaVkFZ?oc=5", "source_name": "Kalkine Media", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - Hemogenyx Pharma Plc - Issue of Equity - Correction", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQdkxzc2dubFhiZ3dnNDd2S2laOGdZMnVaQzJfVTlOdmxibzVYNVR1OGprVzNkSTRlRFNPSjdGQ1EtUERXOWo2Vks0cnV6YUllTTJWMmYzUTlsMU93cXBJeEFaX0pJaUZ5cmdybXZVa2JSNTItcUpNckl3LWk5b215cnpwWVlCQ3dBNDR2Yjl5bVc1aTVUSUlQMEp4eVhiemMxaHhUUkw2ZmxaV0hQNF9LZVcxRGpmYkc0Zi1tX2V6aGVWYW13aUE?oc=5", "source_name": "TradingView", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech Hemogenyx adds new shares, reshaping who holds voting power", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNWFl6T1hDbnFJMnN2Y2k5U0pVVHpEZnU5QU0tWGhoYXBCVkhkU1A5U2hfZVlieDVLNDhOS1FlTlFQODRUajI0dkM0VmJzZTFXdVZvZVhCcFM0aDVqMHlSYmJ0eVZjZ1RlV01tNnc2bnZfOWZwaWF1WmRQWDFwWm4yMzF1d3F0SkJOVmlINWdBd3dMUVZnRTRHOGdn?oc=5", "source_name": "Stock Titan", "published_at": "2025-12-17T08:00:00+00:00", "published_display": "17 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemogenyx Pharmaceuticals PLC (LON: HEMO) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQaUNSYkpvQnBUQkhFTFVDSTZIaE10Vk9vMU5rM2xPWnd0b3NQYlNyTlZVVk5xdGxkbEJuNVpqaXNtMmUyaHU3VDF3NzNTcXB3ejNXWnp5QjE1X2dobURvQU43dmM5cUlKdTlrVWxKc1V1VVRvUkRfOW85LU43VndFLXFBQ3ZYSzhVeGhGd0pSY29LQ09HQW9HdUo2TkQ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2024-09-26T22:08:39+00:00", "published_display": "26 Sep 2024 22:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemogenyx Pharma Share Chat & Price (HEMO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTFBBZ3RLdFo1U2J0R0RLUjNPV3NpMF9IMGx0bzhKTFlya0o0OE1LZzFCS2dQODgwb1U4emRHclF4ZjJuR3dhRm9Xc2hTeFRyc0ZRb2VKOG5qNktqeTVkTXQ1aGFaZjd6NXlxb1JqblVtdw?oc=5", "source_name": "Investing.com UK", "published_at": "2017-02-17T11:35:52+00:00", "published_display": "17 Feb 2017 11:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPVzBaSG8tTXJoOGhTRFo0aVNBa0ZGSGtnQXJEUlRPdUVISWt6OEVnRjk2OW15TkNMTThpbUhDU0xpTzBVWkU4b05UNnhxNWIzMmlkOFhTbnF0UDNsRWEzTEVKbWpKUk9GVWRfWldHMXpvZm5PR194M1ZhMGFrWWRHMGV2WHNaTmFZQVJHWnNlbTUzSTU2dnA0dTdVandlMlVvR2Nmc3FZNDc3ZVJmbi13azZwX0RSUFJNX3c?oc=5", "source_name": "Barchart.com", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemogenyx Issues Director Options During FTSE AIM Developments", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPQ2NZX3BvN0x4aTVyWFZhcm43MnFfUDE3Rnc0bzZyU2ZRVTBxVXdXWXdqRHpodFdwb3hKRWItcUVPVmZZVmxON04td2VBb3NHMlZaZzJkMEJHTXFySXVzT2lTSzRuc3BQSEtlUFBTQlhGa2d2VFRXa1p6T04wZnp2NW1pZUtNX2dVV3U0LXV1bnFHaTdjMFZDbHc3V1BRMlVnRVl5REtHSEQzQW8?oc=5", "source_name": "Kalkine Media", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemogenyx opens child arm in cell therapy trial after safety signoff", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOU012UDVBZll3NmNKZlMyS0FVbUJqMDAzWGlvRUY4ZHEwcmpYQmZtMGYtV2c1alUzUER1WktvbmJGVXVucnl4VW55SmpEYjJXOTZHdy01WHMyWmFhVEU5ZXVkRWJhNFR3SGsybEtCcUdUdFVVem1VNmt2ZVVuc3lYRzZwUS1DS3dYZHhtZzA5WmR5VzRIejQ5c3dLZVM3VEJVREdB?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemogenyx Pharmaceuticals PLC Announces Final Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPemRFMEpSbzZUdjh1dnVoa3ZLZVU2Y1FuNzJUNG11SVpvTWpUQVJjOXA4YXlla0dpcEVLS2l2QzZYdjJIcnBNMWg5WWd1dGZfZEJqWEhGSktlTDkxWWZBMXV1RC1RWUFOLWxHemdHYW0wZVRLRlQxVTE3OGhRMDI5VUhYTWE4OUhJSm42Y3lUTzJlVllVRGZDcVN0X1dHZnlZb0hVcnp2VFNLZFAzLUNkdzdiZWU?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "\u00a33M backs Hemogenyx leukemia trial and Estonia manufacturing", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOM3FIVVVRbHAzc050bWY2TS1zazBaR1R0bXdVcVJsaGJNRTIwUnZIa1lIY3BqdXRQcWRwc2NRcHZxVzlTR3VnWEx1Y3NCSlVkNDVzQ2daZ0R3aTNXYW9xRVF0M3l6ZlJOZE9SazJObl8zTURuN3ppVUpIVEQtX3pSRkhBdzdnUXBtcVVKMkExczFYWWhjZ0Nob2RxdWhRNzVPeHkwSl9ManRYbVMwOVE?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buyers At Hemogenyx Pharmaceuticals Sitting On UK\u00a32.3m Profit", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemogenyx Pharmaceuticals (LSE:HEMO) Market Movement Within FTSE Structure", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOV2l6Q2xVN2ZhR2JrODdFSEtlQUhrOUx4NTQ3Q29hb1hxWFh4bkRYMEUzRldiNjFWdGxxRW9oajhNRkdmS2JubjlPVWxNbUtkcVFYdjM0X2FVTTk1TmxwMUY1cGJtdzFvc2ptVGxRdWFZTzlLSFJNZFBMd1JDS2V0R1VkOXNhWkxTbmtmUkN5S0ZRM2hOR2lCNC1CVVRYTy1iXzF6SWFlLVVsYVp5LUVTbVFSVGFaVkFZ?oc=5", "source_name": "Kalkine Media", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - Hemogenyx Pharma Plc - Issue of Equity - Correction", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQdkxzc2dubFhiZ3dnNDd2S2laOGdZMnVaQzJfVTlOdmxibzVYNVR1OGprVzNkSTRlRFNPSjdGQ1EtUERXOWo2Vks0cnV6YUllTTJWMmYzUTlsMU93cXBJeEFaX0pJaUZ5cmdybXZVa2JSNTItcUpNckl3LWk5b215cnpwWVlCQ3dBNDR2Yjl5bVc1aTVUSUlQMEp4eVhiemMxaHhUUkw2ZmxaV0hQNF9LZVcxRGpmYkc0Zi1tX2V6aGVWYW13aUE?oc=5", "source_name": "TradingView", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech Hemogenyx adds new shares, reshaping who holds voting power", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNWFl6T1hDbnFJMnN2Y2k5U0pVVHpEZnU5QU0tWGhoYXBCVkhkU1A5U2hfZVlieDVLNDhOS1FlTlFQODRUajI0dkM0VmJzZTFXdVZvZVhCcFM0aDVqMHlSYmJ0eVZjZ1RlV01tNnc2bnZfOWZwaWF1WmRQWDFwWm4yMzF1d3F0SkJOVmlINWdBd3dMUVZnRTRHOGdn?oc=5", "source_name": "Stock Titan", "published_at": "2025-12-17T08:00:00+00:00", "published_display": "17 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemogenyx Pharmaceuticals PLC (LON: HEMO) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQaUNSYkpvQnBUQkhFTFVDSTZIaE10Vk9vMU5rM2xPWnd0b3NQYlNyTlZVVk5xdGxkbEJuNVpqaXNtMmUyaHU3VDF3NzNTcXB3ejNXWnp5QjE1X2dobURvQU43dmM5cUlKdTlrVWxKc1V1VVRvUkRfOW85LU43VndFLXFBQ3ZYSzhVeGhGd0pSY29LQ09HQW9HdUo2TkQ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2024-09-26T22:08:39+00:00", "published_display": "26 Sep 2024 22:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hemogenyx Pharma Share Chat & Price (HEMO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTFBBZ3RLdFo1U2J0R0RLUjNPV3NpMF9IMGx0bzhKTFlya0o0OE1LZzFCS2dQODgwb1U4emRHclF4ZjJuR3dhRm9Xc2hTeFRyc0ZRb2VKOG5qNktqeTVkTXQ1aGFaZjd6NXlxb1JqblVtdw?oc=5", "source_name": "Investing.com UK", "published_at": "2017-02-17T11:35:52+00:00", "published_display": "17 Feb 2017 11:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 72, "total_relevant": 11, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 10, "score": 51, "total": 11, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 89, "events": [{"event": "general", "label": "Market update", "weight": 4.95, "count": 9}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 7.75, "latest_week": "2026-07-10", "one_week_move": 0.6, "four_week_move": -6.1, "twelve_week_move": -99.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.601953, "market_dynamics_buy_signal": false, "relative_strength": -98.904851, "fair_value_gap": -98.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 37.0427, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.6% over one week, -6.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 52, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 3}, {"label": "Kalkine Media", "count": 2}, {"label": "Barchart.com", "count": 1}, {"label": "Market source", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "intelligentinvestor.com.au", "count": 1}, {"label": "Investing.com UK", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 11}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 9}, {"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "89/100 classification confidence."}, {"label": "Company focus", "value": "11", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.6% over one week, -6.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector?"}], "updated_at": "2026-07-17T18:12:59.472583+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}